Therapy Development by Genome Editing of Hematopoietic Stem Cells
Accessibility of hematopoietic stem cells (HSCs) for the manipulation and repopulation of the blood and immune systems has placed them at the forefront of cell and gene therapy development. Recent advances in genome-editing tools, in particular for clustered regularly interspaced short palindromic r...
Main Authors: | Lola Koniali, Carsten W. Lederer, Marina Kleanthous |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/6/1492 |
Similar Items
-
Persistence of CRISPR/Cas9 gene edited hematopoietic stem cells following transplantation: A systematic review and meta‐analysis of preclinical studies
by: Harinad B. Maganti, et al.
Published: (2021-07-01) -
Design and optimization of engineered nucleases for genome editing applications
by: Lin, Yanni
Published: (2016) -
Mojo Hand, a TALEN design tool for genome editing applications
by: Neff Kevin L, et al.
Published: (2013-01-01) -
A Nonhuman Primate Transplantation Model to Evaluate Hematopoietic Stem Cell Gene Editing Strategies for β-Hemoglobinopathies
by: Olivier Humbert, et al.
Published: (2018-03-01) -
Enhanced Transduction of Human Hematopoietic Stem Cells by AAV6 Vectors: Implications in Gene Therapy and Genome Editing
by: Hua Yang, et al.
Published: (2020-06-01)